Status:
RECRUITING
Intravenous Antibiotic Treatment at Home
Lead Sponsor:
Helse Møre og Romsdal HF
Collaborating Sponsors:
SINTEF Health Research
Kristiansund municipality
Conditions:
Infection
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for ...
Detailed Description
This research-based innovation study has an evaluation approach with follow-up evaluation as the overall approach. The pre-project was carried out with a qualitative approach under the auspices of SI...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Main or bi-diagnosis during stay:
- A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract
- Competent to give consent
- The infection can not be treated with oral antibiotics in monotherapy
- Selected IV antibiotics must be suitable for administration via selected pumps
- The patient's condition is stable and does not require frequent observation by health care professionals
- The patient is motivated and willing to participate in intravenous treatment in home hospitals
- Must, after training, demonstrate mastery of practical procedures related to pump handling and any other procedures described in the patient's treatment plan
- The home must be suitable for intravenous antibiotic treatment; access to refrigerators, hygienic conditions, social conditions
- The patient must have a mobile phone and be able to handle the system for fast and secure communication with the Regional Response Center (RRO)
- Exclusion criteria:
- consent not given
Exclusion
Key Trial Info
Start Date :
July 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04898452
Start Date
July 2 2020
End Date
December 31 2026
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling
Kristiansund, Norway